Lexeo Therapeutics announces oral presentation of LX2006 at MDS 2026
Lexeo Therapeutics said LX2006 will be presented orally at the International Congress of Parkinson’s Disease and Movement Disorders 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.